Leuzzi, G.; Sabia, F.; Calderoni, M.; Uslenghi, C.; Pastorino, U.; Marchianò, A.; Ferrari, M.; Pardolesi, A.; Lorenzini, D.; Lo Russo, G.;
et al. Leveraging Landmark Analysis for Tailored Surveillance in Stage I Non-Small-Cell Lung Cancer. Cancers 2026, 18, 367.
https://doi.org/10.3390/cancers18030367
AMA Style
Leuzzi G, Sabia F, Calderoni M, Uslenghi C, Pastorino U, Marchianò A, Ferrari M, Pardolesi A, Lorenzini D, Lo Russo G,
et al. Leveraging Landmark Analysis for Tailored Surveillance in Stage I Non-Small-Cell Lung Cancer. Cancers. 2026; 18(3):367.
https://doi.org/10.3390/cancers18030367
Chicago/Turabian Style
Leuzzi, Giovanni, Federica Sabia, Matteo Calderoni, Clarissa Uslenghi, Ugo Pastorino, Alfonso Marchianò, Michele Ferrari, Alessandro Pardolesi, Daniele Lorenzini, Giuseppe Lo Russo,
and et al. 2026. "Leveraging Landmark Analysis for Tailored Surveillance in Stage I Non-Small-Cell Lung Cancer" Cancers 18, no. 3: 367.
https://doi.org/10.3390/cancers18030367
APA Style
Leuzzi, G., Sabia, F., Calderoni, M., Uslenghi, C., Pastorino, U., Marchianò, A., Ferrari, M., Pardolesi, A., Lorenzini, D., Lo Russo, G., Proto, C., Prelaj, A., & Solli, P.
(2026). Leveraging Landmark Analysis for Tailored Surveillance in Stage I Non-Small-Cell Lung Cancer. Cancers, 18(3), 367.
https://doi.org/10.3390/cancers18030367
